查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1208609

2023-2030 年全球胃球囊手术市场

Global Gastric Balloon Procedures Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

胃球囊手术的全球市场规模预计到 2023 年将达到 4945 万美元，在预测期内（2023 年至 2030 年）以 12.4% 的复合年增长率增长。

胃球囊疗法，又称内窥镜胃内球囊，将1至3个硅胶球囊置入患者胃部数月，使多余体重减少约30%，从而减轻患者体重，是一种改善健康的方法。

市场动态

推动全球胃球囊手术市场的主要因素是：由于 2 型糖尿病发病率上升，胃球囊手术需求增加，其中肥胖是主要原因；这些因素包括肥胖人数增加，提高认识运动，以及导致新产品发布的技术进步。

健身和体质意识的提高以及全球肥胖人数的增加预计将导致新产品的开发并推动市场的增长。

胃球囊手术市场的驱动因素包括健身和结构意识的提高、技术进步的不断增加、老年人口的增加、研发投资的激增、主要由肥胖引起的 2 型糖尿病病例数量的增加、新兴市场的推动。市场医疗基础设施的改善以及采用最新技术的新产品的改进。

胃气球被广泛用于减肥。 这些设备的日益普及导致政府加大了努力和资金投入。 这些资金将支持单层、双层和三层胃球囊产品的生产。 随着患有肥胖症的人数增加，这些胃气球市场在全世界都在增长。 此外，预计主要製造商提供的技术先进的产品也将在市场增长中发挥重要作用。

2022 年 5 月 26 日，以医生为主导的代谢健康和减肥解决方案公司 Reshape Lifesciences 今天宣布，它将推出虚拟护理全栈式交付，以安排以医生为主导的全国远程健康解决方案减肥指导。宣布与服务提供商 OpenLoop 达成协议。

使用胃气球带来的风险和安全问题预计会阻碍市场增长。

然而，用于胃球囊放置手术的硅胶球囊批准的严格规则和法规是抑制胃球囊手术市场增长的主要因素。 这些程序的高成本也是一个限制因素。

与使用这些胃气球和导管相关的风险和安全问题可能会抑制生长。 与这些充满盐水或气体的胃气球相关的高风险可能会导致阻塞，需要通过手术来移除该装置。 其他风险包括急性胰腺炎、过度充气和胃壁溃疡。

COVID-19 影响分析

疫情对全球金融预期、运营和危机应对策略产生了负面影响。 COVID-19 的爆发严重影响了医疗保健行业。 由于 COVID，胃气球手术市场遭受了巨大损失。 主要製造商已经启动了各种研究和临床试验。 世界各地正在开展各种举措、产品发布、合作和合併，以促进市场的增长。 例如，2022 年 10 月 31 日，以医生为主导的代谢健康和减肥解决方案公司 ReShape Lifesciences 宣布，国际肥胖与代谢外科医生联合会 (IFSO) 和美国代谢与减肥外科医生协会 (ASMBS) 将认识到 宣布发布更新的代谢和减肥手术新指南。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 提高对健身和体质的认识
      • 肥胖人口增加
    • 约束因素
      • 使用胃气球时的安全问题
      • 成本高
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 单个胃气球
  • 双胃气球
  • 三层胃气球

第 8 章技术

  • 内窥镜
  • 非内窥镜

第9章通过填充

  • 充满盐水的胃气球
  • 充气胃气球

第 10 章按容量分类

  • 可调节胃气球
  • 不可调节的胃气球

第 11 章最终用户

  • 医院
  • 门诊手术中心
  • 医务室

第12章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第13章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第14章公司简介

  • Apollo Endosurgery Inc.
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • ReShape Lifesciences, Inc.
  • LEXEL S.R.L.
  • Medispar c.v.b.a.
  • Allurion
  • Helioscopie Medical Implants
  • Districlass Medical
  • ENDALIS
  • Accel Medical
  • Silimed, Inc.

第15章 DataM

简介目录
Product Code: DMMD64

Market Overview

The global gastric balloon procedures market size was valued at US$ 49.45 million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 12.4% during the forecast period (2023-2030).

Gastric balloon procedures also called an endoscopic intragastric balloon, is the procedure of inserting 1 to 3 silicon balloons in the stomach of the patient for a few months so that they lose around 30% of excess weight, thereby improving the health condition of the patient.

Market Dynamics

The major factors driving the global gastric balloon procedures market are the rising demand for gastric balloon procedures owing to increasing incidences of type-2diabetes which is mainly caused due to obesity, increasing consciousness on fitness and structure, growing obese population across the globe,, surging awareness initiatives, advancements in technologies leading to novel product launches.

The increasing consciousness on fitness and structure and growing obese population across the globe leading to the development of novel products are expected to drive the market's growth.

The gastric balloon procedures market is driven by increasing consciousness on fitness and structure, rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of type-2 diabetes cases which is mainly caused due to obesity and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The gastric balloon procedures are used widely for weight loss. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce gastric balloon products such as single, dual and triple gastric balloons. The market for these gastric balloons is increasing worldwide due to the enhanced number of people suffering from obesity. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives related to these gastric balloon procedures medications contribute to the market's growth. in May 26, 2022, ReShape Lifesciences, a physician-led metabolic health and weight loss solutions company announced its agreement with OpenLoop, virtual care full-stack delivery services provider, to arrange a physician-led, nationwide, telehealth solution for virtual weight loss coaching.

Risks and safety concerns associated with the use of these gastric balloons are expected to hamper the market's growth.

However strict rules and regulations for the approval of the silicone balloons utilized for procedure of gastric balloon placement is the major factor hindering the growth of the gastric balloon procedures market. High costs of these procedures is also a limiting factor.

The risks and safety concerns associated with the use of these gastric balloons or catheters are likely to hinder the growth. High risk related to these gastric balloons that are filled with either saline or gas can cause a blockage which requires surgery for the removal of device. Other risks are acute pancreatitis, over-inflation and ulcers in the stomach wall.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The gastric balloon procedures market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in October 31, 2022, ReShape Lifesciences, a physician-led metabolic health and weight loss solutions company announced that the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and the American Society for Metabolic and Bariatric Surgery (ASMBS) have issued novel guidelines that have been updated for Metabolic and Bariatric Surgery which include the Lap-Band.

Segment Analysis

The single gastric balloon segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The single gastric balloon segment is the highest market holder in the global gastric balloon procedures market. The global gastric balloon procedures market is segmented based on product type as single gastric balloon, dual gastric balloon and triple gastric balloon. The single gastric balloon segment is the largest market shareholder due to its increasing number of procedures utilizing single gastric ballons globally, increasing technological advancements and novel product launches.

Single gastric balloon is the most commonly used balloon for gastric balloon procedures which is easy to insert as this one time procedure where the doctor will place the catheter inside the stomach and then fill the balloon with either gas or saline water so the person may feel full after eating small amount of food. This balloon will then be removed after 6 months of placement. This whole procedure is done under direct supervision of endoscopy. The procedure involving single gastric balloon is easy to perform.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drives the market's growth. For instance, in November 21, 2022, Apollo Endosurgery, Inc., a minimally invasive medical devices provider for bariatric and gastrointestinal procedures, announced about its successful transition under the European Medical Device Regulation (MDR) of legacy products including for the BIB, OverStitch Systems and Orbera 365 intragastric balloons to CE Mark. The novel certificates were issued by British Standards Institute and are valid for five years.

Geographical Analysis

North America holds the largest market share in the global gastric balloon procedures market.

North America dominates the global gastric balloon procedures market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of gastric balloon procedures such as endoscopic or non-endoscopic like swallowing for weight loss, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the gastric balloon procedures market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in November 29, 2022, Apollo Endosurgery, Inc., a minimally invasive medical device provider company for bariatric and gastrointestinal procedures, announced about entering into an acquisition merger agreement with Boston Scientific Corporation, a medical technology provider company.

Competitive Landscape

The gastric balloon procedures market is moderately competitive with local and global companies' presence. Apollo Endosurgery Inc., ReShape Lifesciences, Inc., LEXEL S.R.L., Medispar C.V.B.A, Allurion, Helioscopie Medical Implants, Districlass Medical, ENDALIS, Accel Medical, Silimed, Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in June 16, 2021, ReShape Lifesciences Inc., a weight-loss solutions provider announced its completion of the announced merger with Obalon Therapeutics. Obalon's name is changed to ReShape Lifesciences Inc. and company's combined common stock will initiate trading under the ticker symbol "RSLS".

ReShape Lifesciences, Inc.

Overview: ReShape Lifesciences is a metabolic health and weight loss-solutions provider company, providing an integrated portfolio of products and services that treat and manage obesity and metabolic disorders.

Product Portfolio:

Obalon Balloon System: It is the first and only gas-filled, swallowable, FDA-approved balloon system specially developed for weight-loss.

The global gastric balloon procedures market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing consciousness on fitness and structure
      • 4.1.1.2. Growing obese population
    • 4.1.2. Restraints:
      • 4.1.2.1. Safety concerns regarding the use of gastric balloons
      • 4.1.2.2. High cost
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Single Gastric Balloon*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Dual Gastric Balloon
  • 7.4. Triple Gastric Balloon

8. By Procedure

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 8.1.2. Market Attractiveness Index, By Placement
  • 8.2. Endoscopic *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Non-Endoscopic

9. By Filling

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 9.1.2. Market Attractiveness Index, By Filling
  • 9.2. Saline-Filled Gastric Balloon*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Gas-Filled Gastric Balloon

10. By Volume

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 10.1.2. Market Attractiveness Index, By Volume
  • 10.2. Adjustable Gastric Balloon *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Non-Adjustable Gastric Balloon

11. By End-User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2. Market Attractiveness Index, By End-User
  • 11.2. Hospitals *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Clinics

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Products Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. Apollo Endosurgery Inc. *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. ReShape Lifesciences, Inc.
  • 14.3. LEXEL S.R.L.
  • 14.4. Medispar c.v.b.a.
  • 14.5. Allurion
  • 14.6. Helioscopie Medical Implants
  • 14.7. Districlass Medical
  • 14.8. ENDALIS
  • 14.9. Accel Medical
  • 14.10. Silimed, Inc.

LIST NOT EXHAUSTIVE

15. Global Gastric Balloon Procedures Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Medications
  • 15.3. Contact Us